Elevai Labs, Inc. (ELAB)
NASDAQ: ELAB · IEX Real-Time Price · USD
0.500
-0.005 (-0.91%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Company Description
Elevai Labs Inc., a skincare development company, designs, manufactures, and markets skincare products in the United States.
The company offers Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions.
It serves dermatologists, plastic surgeons, medical spa owners, and physicians focused on aesthetic and therapeutic skincare.
The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021.
Elevai Labs Inc. was incorporated in 2020 and is based in Newport Beach, California.
Elevai Labs, Inc.
| Country | United States |
| Founded | 2020 |
| IPO Date | Nov 21, 2023 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 18 |
| CEO | Graydon Bensler C.F.A. |
Contact Details
Address: 120 Newport Center Drive, Ste 250 Newport Beach, California 92660 United States | |
| Phone | 18667944940 |
Stock Details
| Ticker Symbol | ELAB |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001840563 |
| ISIN Number | US28622K1043 |
| Employer ID | 85-1399981 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jordan R. Plews Ph.D. | Co-Founder, President, Chief Executive Officer and Director |
| Brenda Buechler | Chief Marketing Officer |
| Christoph Kraneiss | Chief Commercial Officer |
| Dr. Hatem Abou-Sayed F.A.C.S., FACS, M.B.A., M.D., MBA | Co-Founder, Chief Medical Officer and Director |
| Graydon Bensler C.F.A. | Chief Financial Officer, Secretary and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 16, 2024 | 8-K | Current Report |
| Jul 12, 2024 | 8-K | Current Report |
| Jun 26, 2024 | 8-K | Current Report |
| Jun 20, 2024 | 8-K | Current Report |
| May 31, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| May 24, 2024 | 8-K | Current Report |
| May 15, 2024 | 10-Q | Quarterly Report |
| May 9, 2024 | 8-K | Current Report |
| May 2, 2024 | 8-K | Current Report |
| Mar 29, 2024 | 10-K | Annual Report |